About the role#
This is a 12-week full-time internship focused on the computational and experimental design of multispecific antibodies. You will work on-site at our Gaithersburg, Maryland facility from May 24, 2027, to August 13, 2027.
What you'll do#
- Design multispecific antibodies using computational and AI-enhanced approaches.
- Produce multispecific antibodies by running expression and purification workflows.
- Characterize these antibodies using biophysical and functional assays.
What you'll need#
- You are a rising senior or Master's-level student in Chemical Engineering, Biological Engineering, or a related field.
- Your expected graduation date is after August 2027.
- Experience with computational protein modeling, design, and protein engineering.
- Wet-lab experience including molecular cloning, protein purification, in vitro assays, and cell-based assays.
- US work authorization is required at the time of application.
Location & details#
- Location: Gaithersburg, Maryland.
- Schedule: On-site, five days per week.
- Term: Summer 2027.
- This position does not offer relocation assistance or CPT support.
About AstraZeneca
AstraZeneca is a public pharmaceutical manufacturing company. It focuses on research, development, and global business operations. The company maintains offices in Cambridge and Sodertalje. It employs over 80,000 people.
How to get in at AstraZeneca
Securing an internship at AstraZeneca requires speed because early applicants often get seen before the pile grows. Intern Insider sends an instant alert the moment a role matching your target is published anywhere, which helps you apply among the first. You will find that being at the front of the queue is a significant advantage in a competitive field. Reaching out to the right people often beats applying into a generic queue. Intern Insider surfaces the recruiters behind the company roles so you can reach out directly to ask about the role or a referral. This approach materially improves your response rates compared to standard applications.


